.png)
HISTORY
2014
- Development of skin permeable botulinum polypeptide ingredient completed.
- Patent application for 8 major countries PCT/KR2015/005434.
- Registered on International Cosmetic Ingredient Dictionary.
<INCI : Methionyl r-Clostridium Botulinum Polypeptide-1 Hexapeptide-40>
2015
- Registered BoLCA+ trademark.
- Bolca Anti-Wrinkle Facial Serum & Cream Launched (Midaskin Co., Ltd.)
2016
- Established BPMed Cosmetic Co., Ltd.
- Exclusive contract with GBS for Ukraine (Ukraine, Latvia, Estonia, Georgia, Lithuania).
- Exclusive contract with Inist Bio for sales in Korean clinics.
2017
- Exclusive contract with HFB for Vietnam.
- Exclusive contract for Philippine.
- Exclusive contract for Jordan.
- iCure BotaLinium (GS Home Shopping) - Supply of botulinum core ingredient.
- Huderma Hyalinum (Lotte Home Shopping) - Supply of botulinum core ingredient.
- Investment attraction from L&S Venture Capital.
- Venture Business Certification.
- Patent registration completed in Japan JP.6243577.
2018
- Brazil exclusive supply agreement
- China Luxury esthetic chain bulk formula supply agreement
- Biotechnie Line-up launched
2019
- Russia supply agreement
- BoLCA+ trade mark registration in China
- China Luxury esthetic chain finished product supply agreement
- Dermabotul, Botulife Line-up launching
- Korea, USA, Canada, China, Russia patent registration
2020
- Turkey Bdderm Professional products export
- Korea Dermabotul trade mark registration
- Japan Haru BoLCA+ products supply
- Tajikistan CAG BoLCA+ products supply
- EU patent registration
- Swiss ASUL Latin America exclusive supply agreement
- Japan BoLCA+ product exclusive supply agreement
2021
- Change of company name to “BPMed Co., Ltd.”
- Thailand supply agreement for clinic and esthetic shop
- Vietnam product registration and supply agreement
- Hongkong plastic surgery chain supply agreement
- Kingdom of Saudi “Bloom Hyalu Tox PDRN” supply
- China NMPA registration of 7 products (Specific purpose category)
- EU CPNP registration of 3 products
2022
- China supply agreement for the NMPA registered 7 products
- Brazil (Latin America) exclusive supply agreement for the Botulinum Ingredient
- Composition Patent application for hair loss and pain improvement with the Botulinum Ingredient
2023
- EU 6 countries BoLCA+ export supply
- Korea ITF Association BoLCA+ Skin Booster supply
- Japan Reveiller eye cream & facial cream export supply
- Korea Liransi CC Toxin 3 products supply
2024
- UK BoLCA+ Skin Booster export supply
- Korea Arocell Botulinum Ingredient supply
- France Cap Actuel BoLCA+ export supply
- Turkey Ordi Pharma BoLCA+ exclusive supply agreement
- Brazil Airela Pharmaceutica Botulinum Ingredient supply
- Switzerland IMDA SA BoLCA+ export supply
- Brazil Meiskin hair MTS solution supply
- Spain SESDERMA 3 products supply
- Korea SpeBio Botulinum Ingredient supply for Exosome Skin Booster
2025
- Kuwait BoLCA+ Skin Booster exclusive supply agreement
- Ireland BoLCA+ export supply
- Australia BoLCA+ export supply
- Slovakia BoLCA+ export supply
- Iceland BoLCA+ export supply